Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

PCI or CABG, That is the Question!

  • Woo, Jong Shin (Division of Cardiovascular, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine) ;
  • Kim, Weon (Division of Cardiovascular, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine)
  • Received : 2017.03.27
  • Accepted : 2017.04.13
  • Published : 2017.05.31
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol 2011;58:e44-122. https://doi.org/10.1016/j.jacc.2011.08.007
  2. Kang SH, Lee CW, Yun SC, et al. Coronary artery bypass grafting vs. drug-eluting stent implantation for multivessel disease in patients with chronic kidney disease. Korean Circ J 2017;47:354-60. https://doi.org/10.4070/kcj.2016.0439
  3. Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int 2016;90:411-21. https://doi.org/10.1016/j.kint.2016.03.033
  4. Wang ZJ, Zhou YJ, Liu YY, et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J 2009;73:1228-34. https://doi.org/10.1253/circj.CJ-08-1091
  5. Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM. Short- and longterm outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol 2010;106:348-53. https://doi.org/10.1016/j.amjcard.2010.03.037
  6. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery. J Am Coll Cardiol 2015;66:1209-20. https://doi.org/10.1016/j.jacc.2015.06.1334
  7. Palmer SC, Di Micco L, Razavian M, et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev 2013;(2):CD008834.
  8. James S, Budaj A, Aylward P, et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the platelet inhibition and patient outcomes (PLATO) trial. Circulation 2010;122:1056-67. https://doi.org/10.1161/CIRCULATIONAHA.109.933796
  9. Jeong KH, Cho JH, Woo JS, et al. Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study. Am J Kidney Dis 2015;65:916-24. https://doi.org/10.1053/j.ajkd.2014.11.023